首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4~+ and CD8~+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
【24h】

Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4~+ and CD8~+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen

机译:DNA-SIV和NYVAC-SIV初免/加强方案对猿猴免疫缺陷病毒(SIV)特异的CD4〜+和CD8〜+ T细胞反应的增强作用

获取原文
获取原文并翻译 | 示例
           

摘要

T cell-mediated immune responses play an important role in the containment of HIV-1 replication. Therefore, an effective vaccine against HIV-1 should be able to elicit high frequencies of virus-specific CD8~+ and CD4~+ T cells. The highly attenuated poxvirus-based vaccine candidate, NYVAC-SIV-gag-pol-euv (NYVAC-SIV-gpe), has been shown to induce and/or expand SIV-specific CD4~+ and CD8~+ T cell responses in both naive and infected macaque. In this study, the immunogenicity of NYVAC-SIV-gpe alone was compared with a combination regimen where priming with an optimized DNA-SIV-gag-env vaccine candidate was followed by a NYVAC-SIV-gpe boost. In macaques immunized with the prime-boost regimen, the extent and durability of CD8~+ T cell response to an immunodominant SIV gag epitope was increased and these animals recognized a broader array of subdominant SIV epitopes in the cytolytic assay. In addition, the prime-boost regimen significantly enhanced the proliferative respeonses to both SIV gag and env proteins. Thus, the combination of these vaccine modalities may represent a valuable strategy in the development of a vaccine for HIV.
机译:T细胞介导的免疫反应在遏制HIV-1复制中起着重要作用。因此,一种有效的抗HIV-1疫苗应该能够引起高频率的病毒特异性CD8〜+和CD4〜+ T细胞。已显示高度减毒的基于痘病毒的候选疫苗NYVAC-SIV-gag-pol-euv(NYVAC-SIV-gpe)可以诱导和/或扩展SIV特异性CD4〜+和CD8〜+ T细胞反应天真和感染猕猴。在这项研究中,将NYVAC-SIV-gpe单独的免疫原性与联合方案进行了比较,在联合方案中,先用优化的DNA-SIV-gag-env候选疫苗进行初次免疫,然后进行NYVAC-SIV-gpe加强免疫。在用初免-加强方案免疫的猕猴中,CD8 + T细胞对免疫优势SIV gag表位的反应的程度和持久性增加,这些动物在溶细胞测定中认识到更广泛的次要SIV表位。此外,初免-加强疗法显着增强了对SIV gag和env蛋白的增殖反应。因此,这些疫苗形式的组合可能代表了开发HIV疫苗的有价值的策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号